IVRN (Innoveren Scientific) Other Financing: $0.04 Mil (TTM As of Sep. 2023)


IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Other Financing?

Innoveren Scientific IVRN 16 Other Financing is $0.04 Mil as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

Innoveren Scientific's Other Financing for the three months ended in Sep. 2023 was $0.00 Mil.

Innoveren Scientific's Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 was $0.04 Mil.

Innoveren Scientific Other Financing Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Other Financing Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.61 0.00 0.00 0.00 1.17

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.04 0.00 0.00 0.00
IVRN
16GF Score
Innoveren Scientific Inc IVRN
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.04 Mil mean?
Innoveren Scientific (IVRN) has a Other Financing of $0.04 Mil as of Sep. 2023. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Innoveren Scientific and its competitors.
Is Innoveren Scientific's Other Financing too high?
Innoveren Scientific's current Other Financing is $0.04 Mil. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Other Financing compare to GNCA and ISCO?
Innoveren Scientific's Other Financing of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Innoveren Scientific and its competitors. Innoveren Scientific's current Other Financing is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Other Financing of $0.04 Mil. The current Other Financing is $0.04 Mil. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Other Financing is $0.04 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price